Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi

Melanoma Research

Volumn 21, Issue 5, 2011, Pages 389-394

  Konstantina, Anagnostopoulou ^a   Lazaris, Andreas C ^a   Ioannidis, Eleftherios ^a   Liossi, Anna ^a   Aroni, Kyriaki ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

angiogenesis; dysplastic nevus; expression; histopathological; hypoxia inducible factor 1 a; melanoma; placental growth factor; vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLACENTAL GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DYSPLASTIC NEVUS; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION;

DYSPLASTIC NEVUS SYNDROME; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; PARAFFIN EMBEDDING; PREGNANCY PROTEINS; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052682410     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328347ee33     Document Type: Article

References (28)

1. Elder DE, Elenitsas R, Murphy G, Xiaowei X. Benign pigmented lesions and malignant melanoma. In: Elder DE, Elenitsas R, Johnson BL, Murphy GF, editors. Lever's histopathology of the skin. 2008;10th ed. Philadelphia: Lippincott-Raven Publishers. pp. 699-791.
2. Vacca A, Ria R, Ribatti D, Bruno M, Dammacco F. Angiogenesis and tumor progression in melanoma. Recenti Prog Med 2000; 91:581-587.
3. Frohlich E, Mack AF, Garbe C, Klessen C. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas. Br J Dermatol 2005; 153:1159-1165. (Pubitemid 41779571)
4. Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS, Coomber BL. Heterogeneous vascular dependence of tumor cell populations. Am J Pathol 2001; 158:1325-1334. (Pubitemid 32281296)
5. Molnar EL, Hegyesi H, Toth S, Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000; 12: 547-554. (Pubitemid 30453481)
6. Pisacane AM, Risio M. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas. Melanoma Res 2005; 15:39-43. (Pubitemid 40354472)
7. Lacal PM, Failla CM, Pagani E, Odorisio T, Schietroma C, Falcinelli S, et al. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol 2000; 115:1000-1007. (Pubitemid 32037443)
8. Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M. Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells. Environ Health Perspect 2002; 110 (Suppl 5):783-788. (Pubitemid 35276866)
9. Tendler DS, Bao C, Wang T, Huang EL, Ratovitski EA, Pardoll DA, et al. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res 2001; 61:3682-3688. (Pubitemid 32694980)
10. Alfranca A, Gutierrez D, Vara A, Aragones J, Vidal F, c-Jun Landazuri M. and Hypoxia-Inducible Factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol Cell Biol 2002; 22:12-22. (Pubitemid 33144252)
11. Tajima N, Schonherr K, Niedling S, Kaatz M, Kanno H, Schonherr R, et al. Ca2 +-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau protein. J Physiol 2006; 571 (Pt 2):349-59.
12. Binley K, Askham Z, Martin L, Spearman H, Day D, Kingsman S, et al. Hypoxia-mediated tumour targeting. Gene Ther 2003; 10:540-549. (Pubitemid 36432605)
13. Hartmann A, Kunz M, Kostlin S, Gillitzer R, Toksoy A, Brocker EB, et al. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 1999; 59:1578-1583. (Pubitemid 29160129)
14. Haritopoulos CN, Lazaris AC, Kavantzas N, Tseleni-Balafouta S, Thomopoulou G, Aroni K. ICAM-1 and b integrin immunoexpression in malignant melanoma cells: can they be used as additional predictors? APMIS 2003; 111:421-429. (Pubitemid 36560542)
15. Stefanou D, Batistatou A, Zioga A, Arkoumani E, Papachristou DJ, Agnantis NJ. Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions. Int J Surg Pathol 2004; 12:133-138. (Pubitemid 38542485)
16. Buscà R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, et al. Hypoxia-inducible factor 1 (alpha) is a new target of microphtalmia- associated transcription factor (MITF) in melanoma cells. J Cell Biol 2005; 170:49-59. (Pubitemid 40994095)
17. Bayer-Garner IB, Hough AJ Jr, Smoller BR. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. Mod Pathol 1999; 12:770-774. (Pubitemid 29383879)
18. Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, et al. Immunohistochemical expression of vascular endothelial growth factor, matrixmetalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocyticlesions. Cancer 2002; 95:1963-1970. (Pubitemid 35222177)
19. Varney ML, Olsen KJ, Mosley RL, Singh RK. Paracrine regulation of vascular endothelial growth factor-a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J Interferon Cytokine Res 2005; 25: 674-678.
20. Bachmann IM, Ladstein RG, Straume O, Naumov GN, Akslen LA. Tumor necrosis is associated with increased alphabeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. BMC Cancer 2008; 8:362.
21. Cowden Dahl KD, Robertson SE, Weaver VM, Simon MC. Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. Mol Biol Cell 2005; 16:1901-1912. (Pubitemid 40471958)
22. Patel PS, Yang S, Li A, Varney ML, Singh RK. Capsaicin regulates vascular endothelial cell growth factor expression by modulation of hypoxia inducing factor-1alpha in human malignant melanoma cells. J Cancer Res Clin Oncol 2002; 128:461-468.
23. Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G, et al. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. FASEB J 2002; 16:1453-1455.
24. Trisciuoglio D, Iervolino A, Zupi G, Del Bufalo D. Involvement of of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol Biol Cell 2005; 16:4153-4162. (Pubitemid 41262885)
25. Cohen C, Zavala-Pompa A, Sequeira JH, Shoji M, Sexton DG, Cotsonis G, et al. Mitogen-actived protein kinase activation is an early event in melanoma progression. Clin Cancer Res 2002; 8:3728-3733. (Pubitemid 35424762)
26. Valencak J, Kittler H, Schmid K, Schreiber M, Raderer M, Gonzalez-Inchaurraga M, et al. Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma. Clin Exp Dermatol 2009; 34:e962-e964.
27. Odorisio T, Cianfarani F, Failla CM, Zambruno G. The placenta growth factor in skin angiogenesis. J Dermatol Sci 2006; 41:11-19. (Pubitemid 43075428)
28. Sun B, Zhang D, Zhang S, Zhang W, Guo H, Zhao X. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 2007; 249:188-197. (Pubitemid 46452927)